Regulation of the T Cell Response by CD39

被引：150

作者：

Takenaka, Maisa C. ^{[1
]}

Robson, Simon ^{[2
,3
,4
]}

Quintana, Francisco J. ^{[1
,5
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA USA

[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Gastroenterol, Boston, MA USA

[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Hepatol, Boston, MA USA

[4] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Transplantat, Boston, MA USA

[5] Broad Inst MIT & Harva, Cambridge, MA USA

来源：

TRENDS IN IMMUNOLOGY | 2016年 / 37卷 / 07期

关键词：

ARYL-HYDROCARBON RECEPTOR; ATP-DIPHOSPHOHYDROLASE ACTIVITY; HYPOXIA-INDUCIBLE FACTORS; FIND-ME SIGNAL; EXTRACELLULAR ATP; DENDRITIC CELLS; TRANSCRIPTIONAL REGULATION; DIFFERENTIAL EXPRESSION; ADENINE-NUCLEOTIDES; HIGH-SENSITIVITY;

D O I：

10.1016/j.it.2016.04.009

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1, or CD39) catalyzes the phosphohydrolysis of extracellular ATP (eATP) and ADP (eADP) released under conditions of inflammatory stress and cell injury. CD39 generates AMP, which is in turn used by the ecto-5'-nucleotidase CD73 to synthesize adenosine. These ectonucleotidases have a major impact on the dynamic equilibrium of proinflammatory eATP and ADP nucleotides versus immunosuppressive adenosine nucleosides. Indeed, CD39 plays a dominant role in the purinergic regulation of inflammation and the immune response because its expression is influenced by genetic and environmental factors. We review the specific role of CD39 in the kinetic regulation of cellular immune responses in the evolution of disease. We focus on the effects of CD39 on T cells and explore potential clinical applications in autoimmunity, chronic infections, and cancer.

引用

页码：427 / 439

页数：13

共 50 条

[1] CD39 Regulation and Functions in T Cells
Timperi, Eleonora
Barnaba, Vincenzo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
[2] Immune-regulation of CD39 on Regulatory T cells
Siddiqui, Shafiuddin
Da Cunha, Andre Pires
Weiner, Howard L.
JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 165 - 166
[3] Characterization of CD39 expression in cutaneous T cell lymphomas
Battesti, G. B.
Thonnart, N.
Bozonnat, A.
Ram-Wolff, C.
de Masson, A.
Bensussan, A.
Bagot, M.
Marie-Cardine, A.
Battistella, M.
EUROPEAN JOURNAL OF CANCER, 2022, 173 : S28 - S28
[4] UNCOUPLING CD39 AND T CELL ANTIGEN SPECIFICITY IN BRAIN TUMORS
Kleist, Sierra
Musial, Shawn
Degefu, Hanna
Rosato, Pamela
Isaacs, Jordan
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1074 - A1074
[5] CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression
Rosa Bono, Maria
Fernandez, Dominique
Flores-Santibanez, Felipe
Rosemblatt, Mario
Sauma, Daniela
FEBS LETTERS, 2015, 589 (22) : 3454 - 3460
[6] CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis
Gupta, Vikas
Katiyar, Shobhita
Singh, Ankita
Misra, Ramnath
Aggarwal, Amita
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (08) : 1548 - 1556
[7] CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells-Response
Canale, Fernando P.
Ramello, Maria C.
Nunez, Nicolas
Bossio, Sabrina N.
Piaggio, Eliane
Gruppi, Adriana
Rodriguez, Eva V. Acosta
Montes, Carolina L.
CANCER RESEARCH, 2018, 78 (17) : 5175 - 5175
[8] CD39 and CD73: targets for immune regulation by moxibustion
Wu, Qiaofeng
PURINERGIC SIGNALLING, 2018, 14 : S73 - S73
[9] Review immune response of targeting CD39 in cancer
Yao Liu
Zhongliang Li
Xiaoguang Zhao
Jing Xiao
Jiacheng Bi
Xian-Yang Li
Guokai Chen
Ligong Lu
Biomarker Research, 11
[10] Regulatory T cells and CD39 expression in transplantation
Dwyer, Karen
Robson, Simon
PURINERGIC SIGNALLING, 2010, 6 : 26 - 26

← 1 2 3 4 5 →